Treatment of lymphangiomas of the head and neck in children by intralesional injection of OK-432 (Picibanil).

The treatments previously used for lymphangiomas of the head and neck in children-surgery and intralesional injection of sclerosants-are associated with significant morbidity. A new treatment-intralesional injection of OK-432-was used for lymphangiomas of the head and neck in 11 children. The results were total shrinkage in two, marked shrinkage in two, slight shrinkage in five and no response in two. The results were not affected by previous surgery nor by whether aspiration prior to injection was possible. There were no recurrences in those children in whom shrinkage occurred and no child had subsequent surgery following injection. The results of this series support those of previous series showing that OK-432 injection is an effective and safe treatment for lymphangiomas of the head and neck in children.
AuthorsC Brewis, J P Pracy, D M Albert
JournalClinical otolaryngology and allied sciences (Clin Otolaryngol Allied Sci) Vol. 25 Issue 2 Pg. 130-4 (Apr 2000) ISSN: 0307-7772 [Print] ENGLAND
PMID10816217 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Picibanil
  • Adolescent
  • Antineoplastic Agents (therapeutic use)
  • Child
  • Child, Preschool
  • Drug Administration Routes
  • Female
  • Head and Neck Neoplasms (diagnosis, drug therapy)
  • Humans
  • Infant
  • Injections
  • Lymphangioma (diagnosis, drug therapy)
  • Male
  • Picibanil (therapeutic use)
  • Tomography, X-Ray Computed
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: